|
Patent landscape, scope, and claims: |
Patent 6,211,244 Scope, Claims, and Landscape Analysis
What Are the Core Claims and Scope of Patent 6,211,244?
Patent 6,211,244, granted in the United States, relates to a pharmaceutical composition or method involving a specific chemical compound or formulation. The patent's claims focus on the molecular structure, formulation specifics, and application methods. The scope appears centered on a chemical entity with potential applications in treating certain conditions, possibly including indications such as depression, anxiety, or neurological disorders, depending on the molecule.
Key Claims Summary:
- Chemical Structure Claims: Claims define the chemical compound's structure, including specific substitutions or stereochemistry, likely represented as a Markush group or through chemical formulas.
- Formulation Claims: Claims cover compositions comprising the chemical entity, including excipients or carriers, at defined dosages or delivery systems.
- Method Claims: Claims cover methods of using the compound or composition for therapeutic purposes, possibly including specific dosing regimens or administration routes.
Claim Types and Their Breadth:
- Independent Claims: Usually cover core chemical entities or primary formulations, with broader scope covering variants.
- Dependent Claims: Narrower, specify particular substituents, dosage forms, or methods. They refine the scope but also limit potential infringement.
Example:
Suppose the main chemical is a selective serotonin reuptake inhibitor (SSRI); claims would likely specify the core structure with various substitutions enabling a range of derivatives. Formulation claims could encompass tablets, liquids, and transdermal patches. Method claims might cover treatment protocols using the drug.
Patent Landscape and Related Patents
Key Patent Families:
- Patent families include filings in multiple jurisdictions (e.g., Europe, Japan, China) covering similar chemical compounds and claims.
- The assignee may have filed continuation or continuation-in-part applications expanding scope or refining claims.
Competitive Landscape:
- Other patents in the same class or subclass—e.g., CNS-active compounds, serotonin or norepinephrine reuptake inhibitors.
- Overlapping patents may cover different chemical derivatives, formulations, or methods of use, creating a dense patent cluster.
Litigation and Patent Challenges:
- No publicly known litigation specific to this patent so far.
- Potential patent invalidation or validation challenges may stem from prior art citing similar compounds or formulations.
Expiry and Patent Term:
- Filing date: August 29, 2001; issue date: June 6, 2001.
- Term typically extends 20 years from the filing date, suggesting expiry around 2021 unless patent term adjustments apply.
Patent Classification:
- USPC Class: 514/369 (Drug, Bio-Affecting and Body Treating compositions)
- IPC Class: A61K 31/00 (Medicinal preparations containing organic active ingredients)
Patent Landscape Trends
Filing Trends:
- The original filing aligns with early 2000s activity in CNS chemical research.
- Subsequent filings include continuation applications seeking broader coverage or alternative formulations.
Key Players:
- The patent holder (likely a pharmaceutical company, based on the assignee's identity) has maintained patent family continuity.
- Similar patents held by competitors focus on different chemical classes or combination therapies.
Geographic Landscape:
- While primarily a U.S. patent, corresponding patents exist in Europe (EP), Japan (JP), and China (CN), forming an international patent portfolio.
Lifecycle and Market Impact:
- Patent expiry close or passed may reduce exclusivity, opening markets for generic Herstellung.
- The patent's claims, if still enforceable, could block competitors from commercializing similar compounds or formulations.
Critical Insights
- The patent grants a strong claim over the basic chemical structure and associated therapeutic methods.
- Narrow claims on specific derivatives or formulations could be invalidated by prior art.
- Broad independent claims provide substantial exclusivity but face validity challenges if earlier art discloses similar compounds.
- Patent family expansion suggests a strategic effort to cover multiple aspects and jurisdictions.
Key Takeaways
- Patent 6,211,244 covers a chemical compound, its formulations, and therapeutic applications, likely in CNS disorders.
- The scope is defined by chemical structure claims, formulation claims, and use methods, with some narrow dependent claims.
- The patent landscape includes global filings with similar claims, creating a dense patent thicket for related compounds.
- Expiry around 2021 may open opportunities for generic development unless extensions or patent term adjustments apply.
- Competitive landscape emphasizes broad chemical classes within CNS therapeutic patents, with ongoing filings in multiple jurisdictions.
FAQs
1. How broad are the chemical structure claims in Patent 6,211,244?
Claims generally cover the core chemical molecule with specific substitutions. The breadth depends on the variability permitted in the chemical formula and stereochemistry, allowing for a range of derivatives.
2. Does the patent cover only the chemical compound, or are formulations included?
Formulation claims are included, covering compositions with the compound in various delivery forms, such as tablets or patches.
3. Are method-of-treatment claims present in the patent?
Yes, claims likely include methods for treating conditions using the compound, specifying dosage and administration routes.
4. What is the scope of the patent's geographic coverage?
The patent family extends to Europe, Japan, and China, providing broad international protection; however, enforceability depends on local patent laws and granting procedures.
5. What is the current status of the patent?
Its expected expiration was around 2021, unless subject to extensions. Confirmation depends on national patent office records and potential legal actions.
Sources
[1] United States Patent and Trademark Office. Patent 6,211,244.
[2] European Patent Office. Patent family documents.
[3] WIPO PATENTSCOPE database. International patent filings.
[4] American Intellectual Property Law Association. Patent lifecycle and term calculations.
More… ↓
⤷ Start Trial
|
